Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies;
Dyskinetic and spastic movement disorders;
Epilepsy;
Glaucoma;
HIV / AIDS;
Huntington’s disease;
Inflammatory bowel disease;
Intractable seizures;
Multiple sclerosis;
Neurodegenerative diseases;
Neuropathies;
Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions;
Parkinson’s disease;
Post-traumatic stress disorder;
Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain;
